Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Unicycive Therapeutics, Inc. - Common Stock (NQ:UNCY)

4.060 -0.090 (-2.17%)
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 7, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 293,042
Open 4.190
Bid (Size) 4.020 (11)
Ask (Size) 4.200 (2)
Prev. Close 4.150
Today's Range 4.040 - 4.246
52wk Range 2.020 - 11.00
Shares Outstanding 14,508,063
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Unicycive Therapeutics, Inc. - UNCY
From Pomerantz LLP
Via GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Unicycive Therapeutics, Inc. - UNCY
From Pomerantz LLP
Via GlobeNewswire

Performance

YTD
-48.8%
-48.8%
1 Month
-18.3%
-18.3%
3 Month
-34.7%
-34.7%
6 Month
-33.3%
-33.3%
1 Year
+16.8%
+16.8%

More News

Read More
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Unicycive Therapeutics, Inc. - UNCY
From Pomerantz LLP
Via GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Unicycive Therapeutics, Inc. - UNCY
From Pomerantz LLP
Via GlobeNewswire
UNCY Investors Have Opportunity to Join Unicycive Therapeutics, Inc. Fraud Investigation With the Schall Law Firm
From Schall Law Firm
Via Business Wire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Unicycive Therapeutics, Inc. - UNCY
From Pomerantz LLP
Via GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Unicycive Therapeutics, Inc. - UNCY
From Pomerantz LLP
Via GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Unicycive Therapeutics, Inc. - UNCY
From Pomerantz LLP
Via GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Unicycive Therapeutics, Inc. - UNCY
From Pomerantz LLP
Via GlobeNewswire
Kaplan Fox & Kilsheimer LLP is Investigating Unicycive Therapeutics, Inc. (UNCY) for Potential Securities Law Violations
Via NewMediaWire
Kaplan Fox & Kilsheimer LLP is Investigating Unicycive Therapeutics, Inc. (UNCY) for Potential Securities Law Violations
Via TheNewswire.com
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Which stocks are moving on Monday?
Via Chartmill
FDA Raises Manufacturing Concerns, Delays Unicycive's Kidney Disease Drug Approval
Via Benzinga
Gapping stocks in Monday's session
Via Chartmill
Get insights into the top gainers and losers of Monday's pre-market session.
Via Chartmill
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Get insights into the top gainers and losers of Tuesday's pre-market session.
Via Chartmill
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Kaplan Fox Alerts Investors of Unicycive Therapeutics to an Investigation of Possible Securities Law Violations
Via NewMediaWire
Kaplan Fox Alerts Investors of Unicycive Therapeutics to an Investigation of Possible Securities Law Violations
Via TheNewswire.com
Kaplan Fox is Investigating Unicycive Therapeutics, Inc. (UNCY) for Potential Securities Law Violations
Via NewMediaWire
Kaplan Fox is Investigating Unicycive Therapeutics, Inc. (UNCY) for Potential Securities Law Violations
Via TheNewswire.com
Kaplan Fox Announces an Investigation Into Unicycive Therapeutics, Inc. (UNCY) for Potential Securities Law Violations
Via TheNewswire.com

Frequently Asked Questions

Is Unicycive Therapeutics, Inc. - Common Stock publicly traded?
Yes, Unicycive Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Unicycive Therapeutics, Inc. - Common Stock trade on?
Unicycive Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Unicycive Therapeutics, Inc. - Common Stock?
The ticker symbol for Unicycive Therapeutics, Inc. - Common Stock is UNCY on the Nasdaq Stock Market
What is the current price of Unicycive Therapeutics, Inc. - Common Stock?
The current price of Unicycive Therapeutics, Inc. - Common Stock is 4.060
When was Unicycive Therapeutics, Inc. - Common Stock last traded?
The last trade of Unicycive Therapeutics, Inc. - Common Stock was at 08/07/25 04:00 PM ET
What is the market capitalization of Unicycive Therapeutics, Inc. - Common Stock?
The market capitalization of Unicycive Therapeutics, Inc. - Common Stock is 58.90M
How many shares of Unicycive Therapeutics, Inc. - Common Stock are outstanding?
Unicycive Therapeutics, Inc. - Common Stock has 59M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.